N-3 PUFA added to high-fat diets affect differently adiposity and inflammation when carried by phospholipids or triacylglycerols in mice

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Awada, Manar ^a,b   Meynier, Anne ^c   Soulage, Christophe O ^b   Hadji, Lilas ^b   Géloën, Alain ^b   Viau, Michèle ^c   Ribourg, Lucie ^c   Benoit, Berengère ^b,d   Debard, Cyrille ^a   Guichardant, Michel ^b   Lagarde, Michel ^b   Genot, Claude ^c   Michalski, Marie Caroline ^a,b,d,e  

^a CarMeN   (France)

^b Univ Lyon   (France)

^c INRA   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

Adipose tissue; High fat diet; Inflammation; n 3 PUFA; Oxidative stress; Phospholipid; Triacylglycerol

Indexed keywords

4 HYDROXYNONENAL; CD14 ANTIGEN; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; PHOSPHOLIPID; TOCOPHEROL; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CELL COUNT; CELL SIZE; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDOTOXEMIA; EPIDIDYMIS FAT; FATTY ACID ANALYSIS; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; INFLAMMATION; INSULIN BLOOD LEVEL; JEJUNUM; LIPID COMPOSITION; LIPID DIET; LIVER WEIGHT; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS;

MUS;

EID: 84873731976     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-23     Document Type: Article

References (58)

1. Inflammation and metabolic disorders. Hotamisligil GS, Nature 2006 444 860 867 10.1038/nature05485 17167474 (Pubitemid 46024993)
2. Chronic inflammation links cardiovascular, metabolic and renal diseases. Manabe I, Circ J 2011 75 2739 2748 10.1253/circj.CJ-11-1184 22067929
3. Inflammatory biomarkers: the link between obesity and associated pathologies. Zulet MA, Puchau B, Navarro C, Marti A, Martinez JA, Nutr Hosp 2007 22 511 527 17970534 (Pubitemid 350014429)
4. Endocrine functions of adipose tissue. Waki H, Tontonoz P, Annu Rev Pathol 2007 2 31 56 10.1146/annurev.pathol.2.010506.091859 18039092 (Pubitemid 46448059)
5. Adipokines in inflammation and metabolic disease. Ouchi N, Parker JL, Lugus JJ, Walsh K, Nat Rev Immunol 2011 11 85 97 10.1038/nri2921 21252989
6. Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Todoric J, Loffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhausl W, Stulnig TM, Diabetologia 2006 49 2109 2119 10.1007/s00125-006-0300-x 16783472 (Pubitemid 44168479)
7. Obesity is associated with macrophage accumulation in adipose tissue. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr, J Clin Invest 2003 112 1796 1808 14679176 (Pubitemid 38063703)
8. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H, J Clin Invest 2003 112 1821 1830 14679177 (Pubitemid 38063705)
9. Calorie restriction with a high-fat diet effectively attenuated inflammatory response and oxidative stress-related markers in obese tissues of the high diet fed rats. Park S, Park NY, Valacchi G, Lim Y, Mediators Inflamm 2012 2012
10. Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. Lankinen M, Schwab U, Erkkila A, Seppanen-Laakso T, Hannila ML, Mussalo H, Lehto S, Uusitupa M, Gylling H, Oresic M, PLoS One 2009 4 5258 10.1371/journal.pone.0005258 ?
11. n-3 PUFA: bioavailability and modulation of adipose tissue function. Kopecky J, Rossmeisl M, Flachs P, Kuda O, Brauner P, Jilkova Z, Stankova B, Tvrzicka E, Bryhn M, Proc Nutr Soc 2009 68 361 369 10.1017/S0029665109990231 19698199
12. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Flachs P, Rossmeisl M, Bryhn M, Kopecky J, Clin Sci (Lond) 2009 116 1 16 10.1042/CS20070456
13. Omega-3 Fatty acids for cardiovascular disease prevention. Defilippis AP, Blaha MJ, Jacobson TA, Curr Treat Options Cardiovasc Med 2010 12 365 380 10.1007/s11936-010-0079-4 20842560
14. Cardiovascular effects of fish oils. Leaf A, Beyond the platelet Circulation 1990 82 624 628 10.1161/01.CIR.82.2.624
15. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. Hashimoto M, Hossain S, J Pharmacol Sci 2011 116 150 162 10.1254/jphs.10R33FM 21606627
16. Impact of omega-3 fatty acids in Parkinson's disease. Bousquet M, Calon F, Cicchetti F, Ageing Res Rev 2011 10 453 463 10.1016/j.arr.2011.03.001 21414422
17. Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA, EFSA Journal 2010 8 1461 10.2903/j.efsa.2010.1461
18. Krill for human consumption: nutritional value and potential health benefits. Tou JC, Jaczynski J, Chen YC, Nutr Rev 2007 65 63 77 17345959 (Pubitemid 351804381)
19. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Calder PC, Mol Nutr Food Res 2012 56 1073 1080 10.1002/mnfr.201100710 22760980
20. Dietary oils and phospholipids containing n-3 highly unsaturated fatty acids suppress 2,4-dinitro-1- fluorobenzene-induced contact dermatitis in mice. Morizawa KTY, Tsuchida M, Nakano Y, Hibino H, Tanaka Y, J Jpn Oil Chem Soc 2000 49 59 65 10.5650/jos1996.49.59
21. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. Rossmeisl M, Jilkova ZM, Kuda O, Jelenik T, Medrikova D, Stankova B, Kristinsson B, Haraldsson GG, Svensen H, Stoknes I, Sjovall P, Magnusson Y, Balvers MG, Verhoeckx KC, Tvrzicka E, Bryhn M, Kopecky J, PLoS One 2012 7 38834 10.1371/journal.pone.0038834 22701720
22. Effect of dietary docosahexaenoic acid connecting phospholipids on the lipid peroxidation of the brain in mice. Hiratsuka S, Ishihara K, Kitagawa T, Wada S, Yokogoshi H, J Nutr Sci Vitaminol (Tokyo) 2008 54 501 506 10.3177/jnsv.54.501
23. Effects of dietary docosahexaenoic acid connecting phospholipids on the learning ability and fatty acid composition of the brain. Hiratsuka S, Koizumi K, Ooba T, Yokogoshi H, J Nutr Sci Vitaminol (Tokyo) 2009 55 374 380 10.3177/jnsv.55.374
24. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. Batetta B, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Sanna F, Bisogno T, Uda S, Collu M, Bruheim I, Di Marzo V, Banni S, J Nutr 2009 139 1495 1501 10.3945/jn.109.104844 19549757
25. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Bunea R, El Farrah K, Deutsch L, Altern Med Rev 2004 9 420 428 15656713 (Pubitemid 40066715)
26. Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-alpha. Vigerust NF, Bjorndal B, Bohov P, Brattelid T, Svardal A, Berge RK, Eur J Nutr in press 10.1007/s00394-012-0441-2
27. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI, Lipids 2011 46 37 46 10.1007/s11745-010-3490-4 21042875
28. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM, Nutr Res 2009 29 609 615 10.1016/j.nutres.2009.09.004 19854375
29. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J, Diabetologia 2006 49 394 397 10.1007/s00125-005-0053-y 16397791 (Pubitemid 43185410)
30. Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells. Awada M, Soulage CO, Meynier A, Debard C, Plaisancie P, Benoit B, Picard G, Loizon E, Chauvin MA, Estienne M, Peretti N, Guichardant M, Lagarde M, Genot C, Michalski MC, J Lipid Res 2012 53 2069 2080 10.1194/jlr.M026179 22865918
31. Dietary oxidised frying oil causes oxidative damage of pancreatic islets and impairment of insulin secretion, effects associated with vitamin E deficiency. Chiang YF, Shaw HM, Yang MF, Huang CY, Hsieh CH, Chao PM, Br J Nutr 2011 105 1311 1319 10.1017/S0007114510005039 21205372
32. Oxidation products of polyunsaturated fatty acids in infant formulas compared to human milk-a preliminary study. Michalski MC, Calzada C, Makino A, Michaud S, Guichardant M, Mol Nutr Food Res 2008 52 1478 1485 10.1002/mnfr.200700451 18792926
33. Dietary DHA: time course of tissue uptake and effects on cytokine secretion in mice. Lefils J, Geloen A, Vidal H, Lagarde M, Bernoud-Hubac N, Br J Nutr 2010 104 1304 1312 10.1017/S0007114510002102 20487585
34. A simple method for the isolation and purification of total lipides from animal tissues. Folch J, Lees M, Sloane Stanley GH, J Biol Chem 1957 226 497 509 13428781
35. High performance liquid chromatogrphy methods for vitamin E in tissues. Buttriss JL, Diplock AT, Methods Enzymol 1984 105 131 138 6727661 (Pubitemid 14165380)
36. Improved techniques for studies of adipocyte cellularity and metabolism. Etherton TD, Thompson EH, Allen CE, J Lipid Res 1977 18 552 557 894148 (Pubitemid 8149738)
37. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Calder PC, Mol Nutr Food Res 2008 52 885 897 10.1002/mnfr.200700289 18504706
38. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Wan JB, Huang LL, Rong R, Tan R, Wang J, Kang JX, Arterioscler Thromb Vasc Biol 2010 30 2487 2494 10.1161/ATVBAHA.110. 210054 20705919
39. Dietary polyunsaturated fatty acids and inflammatory mediator production. James MJ, Gibson RA, Cleland LG, Am J Clin Nutr 2000 71 343S 348S 10617994 (Pubitemid 30046139)
40. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, Jebb SA, Int J Obes (Lond) 2006 30 1535 1544 10.1038/sj.ijo. 0803309 (Pubitemid 44470203)
41. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R, Brain Behav Immun 2012 26 988 995 10.1016/j.bbi.2012.05.011 22640930
42. Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. Laugerette F, Furet JP, Debard C, Daira P, Loizon E, Geloen A, Soulage CO, Simonet C, Lefils-Lacourtablaise J, Bernoud-Hubac N, Bodennec J, Peretti N, Vidal H, Michalski MC, Am J Physiol Endocrinol Metab 2012 302 374 E386 10.1152/ajpendo.00314.2011 22094473
43. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Moreno-Navarrete JM, Manco M, Ibanez J, Garcia-Fuentes E, Ortega F, Gorostiaga E, Vendrell J, Izquierdo M, Martinez C, Nolfe G, Ricart W, Mingrone G, Tinahones F, Fernandez-Real JM, Int J Obes (Lond) 2010 34 240 249 10.1038/ijo.2009.242
44. Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers. Regueiro V, Campos MA, Morey P, Sauleda J, Agusti AG, Garmendia J, Bengoechea JA, Eur Respir J 2009 33 273 281 19010986
45. Leptin: a metabolic hormone that functions like a proinflammatory adipokine. Otero M, Lago R, Gomez R, Lago F, Gomez-Reino JJ, Gualillo O, Drug News Perspect 2006 19 21 26 10.1358/dnp.2006.19.1.966243 16550253
46. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, Nenseter MS, Christiansen EN, Drevon CA, J Lipid Res 2001 42 743 750 11352981 (Pubitemid 32509598)
47. Anti-inflammatory and anti-atherogenic properties of adiponectin. Ohashi K, Ouchi N, Matsuzawa Y, Biochimie 2012 94 2137 2142 10.1016/j.biochi.2012.06. 008 22713764
48. Comparisons of diets used in animal models of high-fat feeding. Warden CH, Fisler JS, Cell Metab 2008 7 277 10.1016/j.cmet.2008.03.014 18396128 (Pubitemid 351455224)
49. Phospholipid and fatty acid specificity of endothelial lipase: potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues. Chen S, Subbaiah PV, Biochim Biophys Acta 2007 1771 1319 1328 10.1016/j.bbalip.2007.08.001 17905648 (Pubitemid 47499233)
50. Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis. Hung ND, Kim MR, Sok DE, Inflammation 2011 34 147 160 10.1007/s10753-010-9218-z 20490641
51. Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. Lagarde M, Bernoud N, Brossard N, Lemaitre-Delaunay D, Thies F, Croset M, Lecerf J, J Mol Neurosci 2001 16 201 204 discussion 215-221 10.1385/JMN:16:2-3:201 11478375 (Pubitemid 32664780)
52. Relationship between adipocyte size and adipokine expression and secretion. Skurk T, Alberti-Huber C, Herder C, Hauner H, J Clin Endocrinol Metab 2007 92 1023 1033 17164304 (Pubitemid 46465679)
53. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Esterbauer H, Schaur RJ, Zollner H, Free Radic Biol Med 1991 11 81 128 10.1016/0891-5849(91)90192-6 1937131 (Pubitemid 121003917)
54. Cytotoxicity and genotoxicity of lipid-oxidation products. Esterbauer H, Am J Clin Nutr 1993 57 779S 785S Discussion 785S-786S 8475896
55. The determination of glutathione-4-hydroxynonenal (GSHNE), E-4-hydroxynonenal (HNE), and E-1-hydroxynon-2-en-4-one (HNO) in mouse liver tissue by LC-ESI-MS. Warnke MM, Wanigasekara E, Singhal SS, Singhal J, Awasthi S, Armstrong DW, Anal Bioanal Chem 2008 392 1325 1333 10.1007/s00216-008-2383-3 18815773
56. Epithelium-specific glutathione peroxidase, GPx2, is involved in the prevention of intestinal inflammation in selenium-deficient mice. Esworthy RS, Yang L, Frankel PH, Chu FF, J Nutr 2005 135 740 745 15795427 (Pubitemid 40464097)
57. Gastrointestinal glutathione peroxidase prevents transport of lipid hydroperoxides in CaCo-2 cells. Wingler K, Muller C, Schmehl K, Florian S, Brigelius-Flohe R, Gastroenterology 2000 119 420 430 10.1053/gast.2000.9521 10930377 (Pubitemid 30621992)
58. Suppression of oxidative stress by grape seed supplementation in rats. Choi SK, Zhang XH, Seo JS, Nutr Res Pract 2012 6 3 8 10.4162/nrp.2012.6.1.3 22413034